CD24 is a genetic modifier for risk and progression of prostate cancer.
Zhang Y, Li B, Zhang X, Sonpavde GP, Jiao K, Zhang A, Zhang G, Sun M, Chu C, Li F, Wang L, Cui R, Liu R.
Zhang Y, et al. Among authors: cui r.
Mol Carcinog. 2017 Feb;56(2):641-650. doi: 10.1002/mc.22522. Epub 2016 Jul 19.
Mol Carcinog. 2017.
PMID: 27377469
Free PMC article.